Gerresheimer stock slips as margin pressure remains in focus

Gerresheimer stock traded at 31.08 euros on Lang & Schwarz at 17:39 CET on Friday, November 13, 2026, 0.32 percent below the Xetra close of Friday, November 13. The quote was 1.49 percent below the 31.55-euro level reported on Thursday, November 12, giving investors a fresh market update while the company's margin outlook remains in focus.

Quarterly growth meets margin pressure

Gerresheimer's preliminary third-quarter results, released on October 30, showed revenue including business units in the sales process rising 8 percent year over year to 605 million euros. Adjusted EBITDA reached 103 million euros, compared with 106 million euros in the adjusted prior-year quarter.

For the first nine months, revenue was 1.7 billion euros, while adjusted EBITDA fell to 272 million euros from 331 million euros. The adjusted EBITDA margin declined to 17.1 percent in the quarter from 19.0 percent a year earlier. The figures were reported in Gerresheimer's company release.

Drug delivery supports earnings

Containment & Delivery Systems remained the main growth driver. Nine-month revenue in the division rose to 917 million euros from 876 million euros, while adjusted EBITDA increased to 211 million euros from 194 million euros. Its third-quarter adjusted EBITDA margin reached 24.5 percent, supported by demand for drug delivery devices and expanded production capacity.

Performance was weaker in Moulded Glass. Third-quarter revenue reached 169 million euros, but adjusted EBITDA fell to 17 million euros from 29 million euros as inventory reductions lowered capacity utilization.

Next milestones for investors

Gerresheimer expects a stronger fourth quarter with further earnings improvement in line with its guidance. The company plans to publish final third-quarter and nine-month figures in December 2026.

Following the Centor sale, preparations for the Primary Packaging Plastics transaction are progressing. Gerresheimer expects the sale to close in the first quarter of 2027, while comprehensive refinancing is another stated milestone.

The broader European market context is covered in Current market reports.

More news and analyses are available on Gerresheimer stock.